NCT Number,Study Title,Study URL,Acronym,Study Status,Brief Summary,Study Results,Conditions,Interventions,Primary Outcome Measures,Secondary Outcome Measures,Other Outcome Measures,Sponsor,Collaborators,Sex,Age,Phases,Enrollment,Funder Type,Study Type,Study Design,Other IDs,Start Date,Primary Completion Date,Completion Date,First Posted,Results First Posted,Last Update Posted,Locations,Study Documents
NCT00002771,"Chemotherapy, Interferon, and Bone Marrow Transplantation in Treating Patients With Chronic Myelogenous Leukemia",https://clinicaltrials.gov/study/NCT00002771,,UNKNOWN,"RATIONALE: Drugs used in chemotherapy use different ways to stop cancer cells from dividing so they stop growing or die. Combining chemotherapy with bone marrow transplantation may allow the doctor to give higher doses of chemotherapy drugs and kill more cancer cells.

PURPOSE: Randomized phase III trial to compare the effectiveness of various combination chemotherapy regimens or bone marrow transplantation in treating patients with chronic myelogenous leukemia.",NO,Leukemia,BIOLOGICAL: recombinant interferon alfa|DRUG: busulfan|DRUG: cytarabine|DRUG: hydroxyurea|DRUG: idarubicin|PROCEDURE: allogeneic bone marrow transplantation|PROCEDURE: autologous bone marrow transplantation|PROCEDURE: peripheral blood stem cell transplantation|RADIATION: radiation therapy,,,,German CML Study Group,,ALL,"CHILD, ADULT, OLDER_ADULT",PHASE3,750,OTHER,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: |Masking: |Primary Purpose: TREATMENT,GER-CML-3|CDR0000064743|EU-95042,1995-01,,,2003-01-27,,2013-08-02,"III Medizinische Klinik Mannheim, Mannheim, D-68135, Germany",
